Serial Number
88827750
Owner
Ultragenyx Pharmaceutical Inc.Attorney
Brian FocarinoFirst Use Date
Sep 20, 2021
Filing Date
Mar 10, 2020
RARIFY Trademark
Serial Number: 88827750 • Registration: 7463656
Trademark Classes
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Class 16 - Paper Goods
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
March 10, 2020
Registration Date
July 30, 2024
First Use Anywhere
September 20, 2021
First Use in Commerce
September 20, 2021
Published for Opposition
August 11, 2020
Goods & Services
education and training services, namely, seminars, providing non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the field of rare diseases and disorders
printed publications, namely, books, brochures, informational pamphlets, informational cards, and advertisements being signs and boards of paper in the field of rare diseases and disorders
providing a website featuring medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the field of rare diseases and disorders; medical consulting services in the field of rare diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of rare diseases and disorders, and collecting data and information on rare diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of rare diseases and disorders
medical and scientific research information in the field of rare diseases and disorders; compiling data for research purposes in the field of rare diseases and disorders; providing an online network service that enables users to share data in the field of rare diseases and disorders; computer services, namely, creating an on-line community for registered users to obtain feedback from their peers, interact with research data, and share data in the field of rare diseases and disorders; pharmaceutical research services, namely, recruitment of rare disease patients for panels such as pharmaceutical research panels
